ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Improving Hypertension Control in East and Central Harlem

Not Applicable

Completed

Conditions: Hypertension

First Posted Date: 2005-09-21

Last Posted Date: 2005-09-21

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 480

Registration Number: NCT00211666

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Improving Heart Failure Care in Minority Communities

Not Applicable

Completed

Conditions: Systolic Dysfunction
Congestive Heart Failure (CHF)

Interventions: Behavioral: Nurse-management

First Posted Date: 2005-09-21

Last Posted Date: 2015-10-12

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 406

Registration Number: NCT00211874

Locations: 🇺🇸
Metropolitan Hospital, New York, New York, United States
🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
🇺🇸
North General Hospital, New York, New York, United States

and more 1 locations

Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)

Terminated

Conditions: Obsessive Compulsive Disorder
Pathological Gambling

Interventions: Procedure: fMRI

First Posted Date: 2005-09-21

Last Posted Date: 2011-07-14

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 57

Registration Number: NCT00211822

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Preventing Recurrent Stroke in Minority Populations

Not Applicable

Completed

Conditions: Transient Ischemic Attack
Stroke

First Posted Date: 2005-09-21

Last Posted Date: 2014-11-11

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 87

Registration Number: NCT00211731

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers

Phase 2

Completed

Conditions: Hepatitis C

First Posted Date: 2005-09-21

Last Posted Date: 2017-01-27

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 207

Registration Number: NCT00211848

Locations: 🇺🇸
Bronx VA, Bronx, New York, United States

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

Phase 4

Completed

Conditions: Attention Deficit Disorder With Hyperactivity

Interventions: Drug: Atomoxetine
Drug: Methylphenidate

First Posted Date: 2005-09-16

Last Posted Date: 2018-06-06

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 232

Registration Number: NCT00183391

Locations: 🇺🇸
University of Illinois, Chicago - Institute for Juvenile Research, Chicago, Illinois, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia

Phase 4

Completed

Conditions: Schizophrenia
Psychotic Disorders

Interventions: Drug: Placebo
Drug: Pimozide

First Posted Date: 2005-09-12

Last Posted Date: 2015-04-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 76

Registration Number: NCT00158223

Locations: 🇺🇸
Pilgrim Psychiatric Center, W. Brentwood, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
Manhattan Psychiatric Center, New York, New York, United States

Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder

Not Applicable

Completed

Conditions: Schizotypal Personality Disorder

Interventions: Drug: Risperidone
Drug: Placebo

First Posted Date: 2005-09-12

Last Posted Date: 2016-08-04

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 25

Registration Number: NCT00158028

Locations: 🇺🇸
Bronx VA, Bronx, New York, United States

Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Improving the Delivery of Effective Care to Minorities

First Posted Date: 2005-09-05

Last Posted Date: 2013-12-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 1164

Registration Number: NCT00145197

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain

Phase 1

Conditions: Low Back Pain

Interventions: Drug: pamidronate

First Posted Date: 2005-01-14

Last Posted Date: 2010-01-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 44

Registration Number: NCT00101790

Locations: 🇺🇸
The Mount Sinai Medical Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy